EN
Hong Qiangxing to Showcase Neurostimulation and Rehabilitation Technologies at the 91st CMEF Spring Exhibition
Mar.05.2025
Healthcare Electronics Manufacturer Highlights Innovation in TENS, EMS, and tDCS Solutions for the Growing Home Rehabilitation Market
Shenzhen, China – March 2025 — Hong Qiangxing (Shenzhen) Electronics Limited, a manufacturer specializing in TENS pain relief devices, EMS muscle stimulators, neurostimulation technologies, and home healthcare solutions, announced its participation in the 91st China International Medical Equipment Fair (CMEF), taking place from April 8–11, 2025.
As one of the largest and most influential medical trade exhibitions in Asia, CMEF provides a global platform for healthcare manufacturers, distributors, medical professionals, and industry buyers to explore emerging technologies and innovative healthcare solutions.
At this year's exhibition, Hong Qiangxing will showcase its latest developments in neurostimulation, rehabilitation, and home healthcare technologies, including medical-grade TENS devices, EMS muscle stimulation systems, and next-generation tDCS solutions designed for both professional and consumer applications.
The global rehabilitation market continues to evolve as healthcare systems increasingly embrace home-based treatment and long-term wellness management. Rising healthcare costs, aging populations, and advances in portable medical technology are accelerating demand for safe, effective, and accessible rehabilitation devices outside traditional clinical settings.
Among the technologies attracting growing industry attention is transcranial direct current stimulation (tDCS), a non-invasive neurostimulation technology that delivers low-intensity electrical current to targeted areas of the brain. As research into neurostimulation and cognitive wellness continues to advance, tDCS devices are becoming an increasingly important segment within the broader healthcare and wellness technology market.
Supporting these innovations is Hong Qiangxing's dedicated R&D team of more than 20 engineers, bringing together expertise in electronics engineering, firmware development, biomedical technology, software engineering, and industrial design. Through continuous investment in research and product innovation, the company has developed a comprehensive portfolio of electrotherapy and neurostimulation solutions serving rehabilitation, pain management, sports recovery, women's health, and wellness applications.
Visitors to CMEF 2025 will have the opportunity to experience a range of innovative products, including dual-channel and multi-channel TENS and EMS systems, wireless electrotherapy devices, smart APP-controlled therapy solutions, and advanced tDCS technologies. The company will also present its capabilities in customized product development, software integration, and OEM/ODM healthcare manufacturing services.
Quality and regulatory compliance remain central to Hong Qiangxing's global growth strategy. The company maintains FDA Registered Medical Device Manufacturer status (Registration No. 3010402752), multiple FDA 510(k) clearances, ISO 13485:2016 certification (Certificate No. 44638), MDSAP certification (Certificate No. 752971), and FCC and RoHS compliance. These qualifications support product distribution across major healthcare markets worldwide.
“CMEF provides an excellent opportunity to connect with healthcare professionals, distributors, and industry partners from around the world,” said a spokesperson for Hong Qiangxing. “We are excited to showcase our latest developments in TENS, EMS, and neurostimulation technologies while exploring new opportunities for collaboration and innovation in the global healthcare market.”
Today, Hong Qiangxing operates four production lines with a monthly production capacity exceeding 150,000 units and serves more than 5,000 customers worldwide, including leading healthcare brands and top Amazon sellers. With strong manufacturing capabilities, international certifications, and continuous innovation, the company remains committed to helping partners bring competitive healthcare solutions to market.
Visitors are welcome to meet the Hong Qiangxing team during CMEF 2025 to learn more about the company's products, manufacturing capabilities, and customized healthcare solutions.
About Hong Qiangxing
Founded in 2003, Hong Qiangxing (Shenzhen) Electronics Limited specializes in the research, development, and manufacturing of TENS pain relief devices, EMS muscle stimulators, tDCS neurostimulation devices, rehabilitation equipment, and home healthcare products. The company owns the SUNMAS and DOMAS brands and provides comprehensive OEM and ODM services for healthcare brands worldwide. Supported by FDA registration, multiple FDA 510(k) clearances, ISO 13485 certification, and MDSAP certification, Hong Qiangxing products are distributed across global healthcare markets.
